|
NCOR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.668180E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.354100E-02 |
| Normal-vs-Stage2 |
1.687850E-01 |
| Normal-vs-Stage3 |
3.338500E-02 |
| Normal-vs-Stage4 |
2.84729999999733E-06 |
| Stage1-vs-Stage2 |
7.189200E-01 |
| Stage1-vs-Stage3 |
3.529000E-01 |
| Stage1-vs-Stage4 |
4.055800E-03 |
| Stage2-vs-Stage3 |
6.629800E-01 |
| Stage2-vs-Stage4 |
7.058000E-02 |
| Stage3-vs-Stage4 |
1.417180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.098000E-02 |
| Normal-vs-AfricanAmerican |
8.794000E-02 |
| Normal-vs-Asian |
1.304990E-01 |
| Caucasian-vs-AfricanAmerican |
8.941200E-01 |
| Caucasian-vs-Asian |
4.820000E-01 |
| AfricanAmerican-vs-Asian |
3.690000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.663500E-03 |
| Normal-vs-Female |
5.436000E-01 |
| Male-vs-Female |
1.553020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.304450E-03 |
| Normal-vs-Extreme_Weight |
5.802900E-03 |
| Normal-vs-Obese |
2.378200E-01 |
| Normal-vs-Extreme_Obese |
8.877400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.872200E-01 |
| Normal_Weight-vs-Obese |
4.433600E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.418380E-01 |
| Extreme_Weight-vs-Obese |
1.712240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.223800E-01 |
| Obese-vs-Extreme_Obese |
7.083400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.698800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.178800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.441300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.986000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.748400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.483800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.366200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.439310E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.274400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.946400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.349200E-01 |
| Normal-VS-Type2 PRCC |
5.391200E-04 |
| Normal-VS-KIRP CIMP |
4.278100E-02 |
| Normal-VS-Unclassified PRCC |
9.339800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.139900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.425000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.228800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.044000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.711700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.612600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.174700E-04 |
| Normal-vs-N1 |
9.477600E-02 |
| Normal-vs-N2 |
1.581850E-03 |
| N0-vs-N1 |
3.934200E-01 |
| N0-vs-N2 |
5.234200E-01 |
| N1-vs-N2 |
2.821200E-01 |
|
|
